<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1FABEB1C-F05D-41A9-8C14-04AEA9AAB7DC"><gtr:id>1FABEB1C-F05D-41A9-8C14-04AEA9AAB7DC</gtr:id><gtr:name>National Hospital for Neurology and Neurosurgery</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8AA408CB-523D-4948-801C-25788BEA8C9F"><gtr:id>8AA408CB-523D-4948-801C-25788BEA8C9F</gtr:id><gtr:name>Jean Monnet University of Saint Etienne</gtr:name><gtr:address><gtr:line1>23 rue Paul Michelon</gtr:line1><gtr:postCode>F-42023</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1FABEB1C-F05D-41A9-8C14-04AEA9AAB7DC"><gtr:id>1FABEB1C-F05D-41A9-8C14-04AEA9AAB7DC</gtr:id><gtr:name>National Hospital for Neurology and Neurosurgery</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8AA408CB-523D-4948-801C-25788BEA8C9F"><gtr:id>8AA408CB-523D-4948-801C-25788BEA8C9F</gtr:id><gtr:name>Jean Monnet University of Saint Etienne</gtr:name><gtr:address><gtr:line1>23 rue Paul Michelon</gtr:line1><gtr:postCode>F-42023</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/84464828-45BA-499F-B869-0BD27BDF40C3"><gtr:id>84464828-45BA-499F-B869-0BD27BDF40C3</gtr:id><gtr:firstName>Saima</gtr:firstName><gtr:surname>Saeed</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002080"><gtr:id>1632B5FF-35B8-4230-8705-119E775184E0</gtr:id><gtr:title>The Role of Mitochondrial Biogenesis in Muscle Function recovery in Critical Illness</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1002080</gtr:grantReference><gtr:abstractText>Infection can trigger an exaggerated host response by the body (?sepsis?) that can lead to failure of multiple organs and a requirement for prolonged life support in the intensive care unit (ICU). Sepsis is a major worldwide cause of death while survivors often suffer long-term disability, notably muscle weakness. Dysfunction of mitochondria, the energy powerhouses that fuel the cell?s metabolism, appears to be an important mechanism underlying multi-organ failure. The degree of mitochondrial dysfunction relates to poor outcomes in ICU patients. Notably, biological triggers stimulating production of new mitochondria (?biogenesis?) are increased at an early stage in survivors but not in those who eventually die. I therefore wish to explore the relationship between mitochondrial biogenesis and restoration of muscle function in the recovery phase following sepsis in both an animal model and in ICU patients. In the model I propose to also use agents that both activate and inhibit mitochondrial biogenesis to see whether restoration of muscle function is directly affected. In patients recovering from critical illness I will assess whether graded exercise, a stimulator of biogenesis, has a positive effect on mitochondrial capacity and muscle function. If demonstrated, this may offer a new treatment target in clinical practice.</gtr:abstractText><gtr:technicalSummary>Sepsis-induced myopathy and muscle wasting is increasingly recognised as a significant contributor to poor health outcomes from critical illness. A potential mechanism may be insufficient or delayed recovery of mitochondrial (bioenergetic) function. The host lab has shown that bioenergetic failure is associated with poor outcomes in both patients and animals with severe sepsis. They have also shown that early upregulation of markers of mitochondrial biogenesis (production of new mitochondrial protein) is associated with survival in critically ill humans.

I propose to test the hypothesis that stimulation of mitochondrial biogenesis improves functional recovery of skeletal muscle on recovery from sepsis. I aim to characterise the recovery phase of a long-term rat model of faecal peritonitis with respect to restoration of bioenergetic capacity and associated improvements in skeletal muscle structure and function. In the same model, I will then either stimulate (with leptin and rosiglitazone) or inhibit (with chloramphenicol) mitochondrial biogenesis to demonstrate any influence on exercise capacity, histological recovery, and force generation using nerve stimulation.

I will complement these lab studies with a patient study where critically ill patients being weaned from mechanical ventilation will be randomised to a graded exercise regimen (as exercise is known to stimulate biogenesis) or standard rehabilitation. Muscle biopsies will be taken on day 1 after intubation and subsequently on day 7 and, if indicated, Day 21. Markers of biogenesis will be measured and compared with functional and histological recovery.

This study will hopefully demonstrate the importance of mitochondrial biogenesis on functional recovery after severe sepsis. If so, it may lead to a important new treatment paradigm that will facilitate and enhance outcomes in the critically ill patient.</gtr:technicalSummary><gtr:fund><gtr:end>2014-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>239246</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre of Human &amp; Aerospace Physiological Sciences</gtr:department><gtr:description>Sequential changes in mitochondrial complex proteins</gtr:description><gtr:id>B958DC72-0AF8-4445-99F6-4BB169F1CD29</gtr:id><gtr:impact>Abstract from this work to be presented at BTS Winter Meeting 2013 (see publications; 'Preservation of Mitochondrial Oxidative Capacity in Critically Ill Patients Balances Reduction in Mitochondrial Biogenesis&amp;quot;) with formal publication currently ongoing</gtr:impact><gtr:outcomeId>hqMKjotFPtT-1</gtr:outcomeId><gtr:partnerContribution>Data, staff support</gtr:partnerContribution><gtr:piContribution>Determination of sequential changes in mitochondrial complex proteins during critical illness</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jean Monnet University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Exercise Physiology Laboratory</gtr:department><gtr:description>PCR characterisation study</gtr:description><gtr:id>CB47BC3A-8FEA-4B37-9943-F3C13FEEDFD0</gtr:id><gtr:impact>Publication pending in Critical Care Medicine as described elsewhere</gtr:impact><gtr:outcomeId>546d5310a95427.84686280-1</gtr:outcomeId><gtr:partnerContribution>PCR performed to assess protein dynamics</gtr:partnerContribution><gtr:piContribution>Muscle tissue from animal model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Hospital for Neurology and Neurosurgery</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Neuropathology</gtr:department><gtr:description>Histology/Immunohistochemistry</gtr:description><gtr:id>021C4D6B-B2A5-4ED7-B22E-8CA07A7CDAAC</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>ZKwuTNsuP2q-1</gtr:outcomeId><gtr:partnerContribution>Provision of support staff, antibodies and equipment for histology/IHC</gtr:partnerContribution><gtr:piContribution>Provision of muscle biopsies</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Software analysis of immunohistochemistry samples to assess levels of mitochondrial staining. Previously unreported in the literature.</gtr:description><gtr:id>4005DDB3-189E-43C3-B007-813FB5076076</gtr:id><gtr:impact>Increased accuracy and precision of measuring mitochondrial aggregation/numbers in an automated method which in turn reduces labour cost in determining this manually.</gtr:impact><gtr:outcomeId>MyfkvYcjZh4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Software analysis of Mitochondrial staining</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A method of characterising skeletal muscle force and its changes at various time-points is required in an in vivo (animal) model of recovery from sepsis. Modulatory agents can then be employed and their effects seen on muscle recovery. The novel aspect in the technique is the ability to take sequential measurements of muscle force in the same animal during the course of sepsis.</gtr:description><gtr:id>23E87A47-A3CF-4E29-A54C-A7856DD0F356</gtr:id><gtr:impact>Reduction in numbers of animals - terminal experiments at each time-point are reduced. This method of muscle strength measurement allows the animal to undergo a brief anaesthetic, have measurements done, and then recover fully, replacing the need to sacrifice the animal at each time point.</gtr:impact><gtr:outcomeId>gwzdGxxDofm</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In vivo muscle force generation</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4D278123-2AF6-4146-B2CD-E3AB0B3AAFED</gtr:id><gtr:title>S54 Preservation of mitochondrial oxidative capacity in critically ill patients balances reduction in mitochondrial biogenesis</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de8cab90b3b3d05e3d13550a91a5d1dc"><gtr:id>de8cab90b3b3d05e3d13550a91a5d1dc</gtr:id><gtr:otherNames>Astin R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>cmyLAQwpjrr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C898027-EBD9-4456-8DC0-42F9DED17ED5</gtr:id><gtr:title>0030. Effect of exercise training on muscle function in a recovery model of critical illness</gtr:title><gtr:parentPublicationTitle>Intensive Care Medicine Experimental</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/438bf2d986b9a760e1a5f6a66955d8d2"><gtr:id>438bf2d986b9a760e1a5f6a66955d8d2</gtr:id><gtr:otherNames>Sigurta A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546d5102c570c4.81799518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FB44059-7BC1-46FF-A5E9-8448EE50A7AB</gtr:id><gtr:title>Detailed characterization of a long-term rodent model of critical illness and recovery.</gtr:title><gtr:parentPublicationTitle>Critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21015ee7a2e00d8ea29fd23380f920e9"><gtr:id>21015ee7a2e00d8ea29fd23380f920e9</gtr:id><gtr:otherNames>Hill NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0090-3493</gtr:issn><gtr:outcomeId>546c9f9139eba3.96433360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A08A3D7B-412C-460E-8ECC-BFBE6EBD61EA</gtr:id><gtr:title>Renal macrophage infiltration in a rat model of sepsis and recovery</gtr:title><gtr:parentPublicationTitle>ESICM LIVES 2013</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2d53e5aa48c45f049b767797c04e07a"><gtr:id>e2d53e5aa48c45f049b767797c04e07a</gtr:id><gtr:otherNames>Arulkumaran, N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>Xs7RxqmMirz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>864C3573-29B5-47CE-A01C-14A4A5585255</gtr:id><gtr:title>Changes in Exercise Capacity and Muscle Function in a recovery model of sepsis</gtr:title><gtr:parentPublicationTitle>ESICM LIVES 2013</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/068a599e195ddd17e731caa61f333742"><gtr:id>068a599e195ddd17e731caa61f333742</gtr:id><gtr:otherNames>Saeed, S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>cc5sYgjizt3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDD37A34-67C1-4586-BC10-18C7481C0D04</gtr:id><gtr:title>Mitochondria - key roles in sepsis</gtr:title><gtr:parentPublicationTitle>R?animation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce3f70037483da92b21fb9166b272694"><gtr:id>ce3f70037483da92b21fb9166b272694</gtr:id><gtr:otherNames>Saeed S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>WXo7cdXmJzW</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002080</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>74DC189C-F240-42D1-84DD-85475A95ABE8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.7  Physical</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>